Thyroid, Hashimoto’s and Hair Loss: What the Evidence Supports

Thyroid disease causes hair loss and explains far fewer cases than people assume. The mechanism, the base rate, and how to tell it apart from pattern loss.

In the largest series of hair loss patients ever published, 3,028 people with diffuse shedding, thyroid dysfunction turned up in 4.6% of them. Vitamin D deficiency turned up in 72.2%. The thyroid gets blamed for hair loss more often than almost anything else, and it is one of the least common explanations.

That isn’t an argument against checking. Thyroid disease does cause hair loss, the mechanism is well characterised, and it is one of the few causes that is fully reversible by treating the underlying condition. It’s an argument for knowing the base rate before you build a theory on it.

What does explain diffuse hair loss

A retrospective review of 3,028 patients with telogen effluvium recorded what their laboratory workups found.[1]

What turns up in the bloodwork of 3,028 hair loss patients Source: Yorulmaz et al., J Cosmet Dermatol 2022. Vitamin D deficiency 72.2% B12 deficiency 30.7% Iron deficiency anaemia 6.2% Thyroid dysfunction 4.6% Folate deficiency 4.4% Zinc deficiency 2.1% Retrospective chart review, and not every patient received every test, so denominators shift between analytes and selective testing inflates positivity. A finding on a blood test is also not proof of causation. Vitamin D deficiency at 72.2% is close to background in many populations.
Thyroid dysfunction was the fourth most common finding and appeared in under one in twenty patients.

The mechanism, which is more direct than people expect

The intuitive story is that thyroid hormone controls metabolism, hair is metabolically expensive, so a slow metabolism means less hair. That isn’t wrong, but it undersells what’s happening.

The hair follicle is a direct thyroid hormone target organ. In cultured human follicles, T4 upregulated hair matrix keratinocyte proliferation and prolonged anagen, both T3 and T4 reduced apoptosis, and both stimulated pigment production. The follicles were also shown to transcribe the deiodinase genes D2 and D3, meaning they can convert T4 to active T3 locally.[2]

The follicle is not a bystander Source: van Beek et al., J Clin Endocrinol Metab 2008, cultured human hair follicles. Circulating T4 and T3 The follicle itself transcribes D2 and D3 deiodinase, converting T4 to T3 locally Anagen prolonged Matrix proliferation up Apoptosis down Remove the hormone and anagen shortens Follicles fall into telogen together: diffuse shedding Ex vivo organ culture from facelift surgery in euthyroid women. No systemic feedback, no disease state, small n.
Anagen prolongation is the specific lever, which is exactly why deficiency produces telogen effluvium rather than pattern loss.

A useful way to hold it: androgens are a local council making decisions about specific streets, and thyroid hormone is the national grid. When the grid dips, every street dims at once. That’s why thyroid loss is diffuse and pattern loss is a map.

That mechanism predicts the clinical picture correctly. Thyroid hair loss is diffuse, all over, because a hormone circulating everywhere affects every follicle at once. It isn’t patterned, because there’s nothing regional about it.

Hypothyroid, hyperthyroid, and a surprise

Both directions are associated with hair loss, and they aren’t equal. In 500 women with telogen effluvium, split into 248 euthyroid, 150 hypothyroid and 102 hyperthyroid, the hypothyroid group had significantly more severe hair loss. The hyperthyroid group did not differ significantly from euthyroid.[3]

Then a primary care study complicates that neatly. Across 2,035 patients tested, the total diagnostic yield of thyroid testing was 2.1%. Hair loss carried an odds ratio of 21 for an abnormal TSH result, which sounds enormous. But hair loss was one of the features associated with a low TSH, meaning overactive rather than underactive.[4]

What testing everyone actually finds 2,035 patients tested in one UK general practice. Source: Werhun & Hamilton, Fam Pract 2015. DIAGNOSTIC YIELD 2.1% 1.7% had TSH above 4.5 mIU/L 0.3% had TSH below 0.01 97.9% of tests found nothing. HAIR LOSS AS A PREDICTOR OR 21 95% CI 2.0 to 230 And it pointed toward LOW TSH, not the high TSH everyone assumes. A confidence interval running from 2 to 230 means very few events sat behind that estimate. The point estimate of 21 is not stable, and this is a single practice. Read it as “hair loss is worth a TSH”, not as “hair loss means thyroid disease”.
The direction of the association is the interesting part. Clinical intuition runs toward hypothyroidism; this dataset ran the other way.

Hashimoto’s, and the distinction that matters most

Here’s the thing most articles get wrong, and it changes what you should test for.

Thyroid autoimmunity and thyroid dysfunction are different, and they associate with different hair conditions. A meta-analysis of 17 studies covering 262,581 alopecia areata patients and 1,302,655 controls found alopecia areata significantly associated with thyroid peroxidase antibodies and thyroglobulin antibodies, and not significantly associated with diagnosed or serological hypothyroidism or hyperthyroidism.[5]

The antibodies separate the groups. The hormone levels don’t. A case-control study of 102 patients reproduced exactly that pattern at individual-study scale: raised anti-TPO in 5 patients versus 0 controls, significant at p equal to 0.024, while thyroid dysfunction occurred in only 2 patients versus 0 controls and was not significant.[6]

What that reflects is autoimmune clustering. If your immune system is attacking one self-tissue it is somewhat more likely to attack another, and pooled across 18 studies covering 462,945 alopecia areata patients, autoimmune thyroiditis carried an odds ratio of 1.57, well below vitiligo at 6.61.[10] Note also that alopecia areata and androgenetic alopecia are different diseases, and this autoimmune evidence is specific to the former. I could find no source giving thyroid antibody prevalence in pattern hair loss.

Thyroid is not alopecia areata’s headline comorbidity Odds ratios, 462,945 patients vs 11,488,192 controls. Source: Krajewski et al., Int J Dermatol 2025. OR = 1 Vitiligo 6.61 Lupus (SLE) 3.28 Atopic dermatitis 2.63 Autoimmune thyroiditis 1.57 Inflammatory bowel disease 1.20 Case-control studies pooled across heterogeneous populations, with ascertainment bias: patients who see doctors more get diagnosed more.
Autoimmune thyroiditis is one of the weakest associations in the panel. Vitiligo is more than four times stronger, and nobody writes articles about vitiligo causing hair loss.

Worth knowing that the literature is not unanimous. A larger review of 50 studies reached a more pro-screening conclusion, finding higher odds of abnormal thyroid function tests and autoantibodies in alopecia areata patients.[7] The two disagree on what to do clinically, which is itself informative about how strong the underlying signal is.

The ferritin detour, because it is the same mistake

Nearly everyone worried about thyroid and hair is also being told to push their ferritin above 70. The best study on this compared 381 women with hair loss against 76 controls, and the result is worth reading twice.

Among the premenopausal women, at a ferritin threshold of 15 or below, iron deficiency occurred in 12.4% of those with female pattern hair loss, 12.1% of those with chronic telogen effluvium, and 29.8% of the controls. At a threshold of 40, the figures were 58.8%, 63.8% and 72.3%. In that group the controls were the most iron-deficient at both thresholds. Postmenopausally the pattern doesn’t hold, and the numbers run the other way. The finding that survives across both groups is the one in the paper’s conclusion: iron deficiency is common in women and not increased in hair loss patients compared with controls.[8]

That’s the pattern to internalise. A number can be abnormal in a lot of people with hair loss and still not explain the hair loss, because it is equally abnormal in people without it. Without a control group you can’t tell the difference, and most of the advice in this space has no control group behind it.

How to tell thyroid hair loss from pattern hair loss. Thyroid loss is diffuse and affects the whole scalp evenly, including the back and sides, which pattern loss spares. It appears over weeks to a few months rather than years. It usually arrives with other things: fatigue, cold or heat intolerance, weight change, cycle changes, dry skin, brittle nails. And in a study of 300 thyroid patients against 100 healthy controls, alopecia was significantly more common in patients, alongside nail thinning, brittle nails, pruritus and dry skin.[9] Hair loss in isolation, with no other symptoms, is much less likely to be thyroid.

What to test, and what to leave alone

Get a TSH. It’s cheap, it’s one tube of blood, and thyroid disease is one of the few reversible causes on the list. The 2.1% yield figure is an argument against expecting it to be the answer, not against looking.

Add TPO antibodies only if there’s a reason: patchy hair loss rather than diffuse, a personal or family history of autoimmune disease, or an abnormal TSH. That is where the antibody evidence applies. Ordering antibodies for ordinary diffuse shedding will mostly generate anxiety.

Don’t chase ferritin on the basis of hair. The controls in the best-designed study were more deficient than the patients.

And be careful about the recovery timeline, because there’s a gap here I should name. I looked for studies reporting how long hair takes to recover after thyroid treatment, and I couldn’t find one. Not a weak study, none. The commonly quoted three to six months follows the normal telogen-to-anagen lag, which is reasonable physiology and is not a published follow-up figure. If someone gives you a confident number, they’re inferring it too.

The last thing, and it’s the most common error I see. If your hair is thinning at the temples and crown in a recognisable pattern, a normal TSH won’t make that go away, and an abnormal one won’t explain it. Thyroid causes diffuse shedding. Pattern loss is a different mechanism entirely, and I have written about telling diffuse thinning apart from pattern hair loss. Both can be present at once, which is exactly why people spend years treating the wrong one.

I’m Philippe Boissard, a hair-loss and male-physiology researcher and author (M.Sc., Aalborg University). I published a comparative review of finasteride and dutasteride in androgenetic alopecia, openly available at doi.org/10.5281/zenodo.20507736. More of my work is at philippeb.pro.

This article names prescription medication. Education, not medical advice.

References

  1. Yorulmaz A, et al. Telogen effluvium in daily practice: patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium. J Cosmet Dermatol, 2022;21(6):2610-7. doi.org/10.1111/jocd.14413
  2. van Beek N, Bodó E, Kromminga A, et al. Thyroid hormones directly alter human hair follicle functions: anagen prolongation and stimulation of both hair matrix keratinocyte proliferation and hair pigmentation. J Clin Endocrinol Metab, 2008;93(11):4381-8. doi.org/10.1210/jc.2008-0283
  3. Bin Dayel S, et al. Is thyroid dysfunction a common cause of telogen effluvium? A retrospective study. Medicine (Baltimore), 2024;103(1):e36803. doi.org/10.1097/MD.0000000000036803
  4. Werhun A, Hamilton W. Thyroid function testing in primary care: overused and under-evidenced? Fam Pract, 2015;32(2):187-91. doi.org/10.1093/fampra/cmv010
  5. Kinoshita-Ise M, Sachdeva M, Martinez-Cabriales SA. Chronological association between alopecia areata and autoimmune thyroid diseases: a systematic review and meta-analysis. J Dermatol, 2019;46(8):702-9. doi.org/10.1111/1346-8138.14940
  6. Habib A, et al. A case-control study to assess the association of alopecia areata with thyroid dysfunction and thyroid autoimmunity. J Ayub Med Coll Abbottabad, 2023;35(4). doi.org/10.55519/JAMC-04-12361
  7. Lee S, Lee YB, Kim BJ, Lee WS. Screening of thyroid function and autoantibodies in patients with alopecia areata: a systematic review and meta-analysis. J Am Acad Dermatol, 2019;80(5):1410-3. doi.org/10.1016/j.jaad.2018.10.066
  8. Olsen EA, Reed KB, Cacchio PB, Caudill L. Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. J Am Acad Dermatol, 2010;63(6):991-9. doi.org/10.1016/j.jaad.2009.12.006
  9. Takir M, et al. Skin findings in autoimmune and nonautoimmune thyroid disease with respect to thyroid functional status and healthy controls. Turk J Med Sci, 2017;47(3):764-70. doi.org/10.3906/sag-1510-39
  10. Krajewski PK, et al. Immune-mediated disorders in patients with alopecia areata: systematic review and meta-analysis. Int J Dermatol, 2025. doi.org/10.1111/ijd.17895

Get my free hair-loss protocol

The exact evidence-based routine I actually use and recommend: what works, in what order, with no hype. Enter your email on the next page and I’ll send it straight to you.

Send me the free protocol →
Philippe Boissard
Philippe Boissard

Philippe Boissard, M.Sc., is a hair loss researcher and author. He breaks down the science of androgenetic alopecia and the treatments men actually weigh up, working from the primary literature rather than marketing claims. New here? Start with his guide to how hair loss actually works.

Articles: 89

Leave a Reply

Your email address will not be published. Required fields are marked *